American Society of Hirudotherapy

Granulin (leech-derived)

Growth factor and wound-healing modulator — promotes angiogenesis and tissue regeneration.

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Last Updated: May 26, 2026 · ASH Editorial · based on the books
  • Hementerin80 kDa
  • Hementin80 kDa
  • Hementin-Like Protein (HLP-1)80 kDa
  • Leech Collagenase70 kDa
  • Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
  • Leech Apyrase67 kDa
  • Calin65 kDa
  • Hyaluronidase60 kDa
  • Antithrombin III binding protein58 kDa
  • Collagenolytic Fibrinolysin55 kDa
  • Leech Thrombospondin-Like Protein50 kDa
  • Granulin (leech-derived)13 kDa
Molecular weight (kilodaltons) of Granulin (leech-derived) (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.
Page type
Compound profile
Evidence type
Preclinical / biochemical characterization
Evidence level
Preclinical (animal)
Drug vs leech
Purified natural compound

Clinical translation limit

Leech-derived granulin's reported wound-healing and angiogenic activity in preclinical models does NOT establish clinical efficacy. No FDA-approved derivative exists. Distinct from human progranulin-targeted therapeutics in development for unrelated indications.

Molecular Profile

Category
Other
Evidence tier
Preclinical
Molecular weight
13,000 Da
Source species
Hirudo medicinalis

Biological Targets

  • → progranulin pathway, wound-healing

Key Citations

  1. Hong S et al. (1999), Eur J Biochem

External Resources

    Related Other Compounds

    This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.